Australia markets closed

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
16.30-0.93 (-5.40%)
At close: 04:00PM EST
16.35 +0.05 (+0.31%)
After hours: 04:51PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 401.84M
Enterprise value 372.93M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)14.12
Enterprise value/revenue N/A
Enterprise value/EBITDA -110.70

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-54.92%
S&P500 52-week change 314.07%
52-week high 369.77
52-week low 315.52
50-day moving average 327.91
200-day moving average 336.29

Share statistics

Avg vol (3-month) 348.15k
Avg vol (10-day) 342.3k
Shares outstanding 513.12M
Implied shares outstanding 6N/A
Float 89.69M
% held by insiders 176.38%
% held by institutions 16.32%
Shares short (30 Dec 2021) 4107.27k
Short ratio (30 Dec 2021) 41.33
Short % of float (30 Dec 2021) 42.60%
Short % of shares outstanding (30 Dec 2021) 40.82%
Shares short (prior month 29 Nov 2021) 4106.47k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-11.98%
Return on equity (ttm)-20.29%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -3.37M
Net income avi to common (ttm)-3.36M
Diluted EPS (ttm)-0.27
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.91M
Total cash per share (mrq)2.2
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)63.51
Book value per share (mrq)2.19

Cash flow statement

Operating cash flow (ttm)-3.18M
Levered free cash flow (ttm)-1.93M